Rainier Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Rainier Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,050	Closed	-$3.62M	–	177
2016 Q3	$3.62M	Buy	29,050 +1,090	+4%	+$129K	0.23%	143
2016 Q2	$2.97M	Buy	27,960 +2,320	+9%	+$269K	0.14%	163
2016 Q1	$2.94M	Buy	25,640 +5,200	+25%	+$610K	0.13%	180
2015 Q4	$2.91M	Sell	20,440 -380	-2%	-$43.9K	0.11%	166
2015 Q3	$1.87M	Buy	20,820 +5,080	+32%	+$536K	0.07%	174
2015 Q2	$1.81M	Buy	+15,740	New	+$1.65M	0.06%	180

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rainier Investment Management's CBPO Position: Q4 2016 in Review

Rainier Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2016, closing a stake of 29,050 shares — an estimated $3.62M sold.

Rainier Investment Management first reported a position in CBPO in Q2 2015 and held it in 6 quarters. The position peaked at $3.62M in Q3 2016. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

Rainier Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
Rainier Investment Management sold 29,050 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $3.62M.
Rainier Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 6 quarters.
Rainier Investment Management's China Biologic Products Holdings, Inc. position peaked at $3.62M in Q3 2016.
143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on Rainier Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.